论文部分内容阅读
AIM: To determine the utility of the Asia-Pacific colorectal screening(APCS) scoring system and metabolic syndrome components in individual screening for sporadic colorectal cancer.METHODS: The subjects were patients admitted to the Peking University People’s Hospital for colonoscopy between October 2012 and July 2013. Clinical information, including patient willingness to undergo colonos-copy, medical history, endoscopic findings, histology, and other information, was collected, and the patients were grouped according to APCS scores and the presence of metabolic syndrome components. Colorectal tumor detection rates were compared between the groups.RESULTS: A total of 219 patients were included in the study, 108 were male and 111 were female, resulting in a male-to-female ratio of 1:1.03. The average age of the patients was 56.8 ± 13.7 years. According to APCS scores, 88(40.2%) patients were included in the average-risk(AR) group, 113(51.6%) patients were included in the moderate-risk(MR) group, and 18(8.2%) patients were included in the high-risk(HR) group. Colorectal tumors were detected in 69(31.5%) subjects, and the detection rates in the AR, MR, and HR groups were 15.9%, 36.3%, and 77.8%, respectively. The difference in the detection rates between the three groups was statistically significant(P < 0.01). The combined detection rate of colorectal tumors in the APCS MR and HR groups was 42.0%. However, patients in the MR and HR groups who presented with metabolic syndrome components, in particular obesity, exhibited a significantly higher colorectal tumor detection rate(59.5%) than did those without these components(19.2%, P < 0.01) and those who underwent colonoscopy because of doctor’s recommendation(36.5%, P < 0.01). CONCLUSION: The APCS scoring system can be used in individual screening for sporadic colorectal cancer. The combined use of APCS scores and the metabolic syndrome components, in particular obesity, will significantly improve the efficacy of individual colorectal cancer screening.
AIM: To determine the utility of the Asia-Pacific colorectal screening (APCS) scoring system and metabolic syndrome components in individual screening for sporadic colorectal cancer. METHODS: The subjects were patients admitted to the Peking University People’s Hospital for colonoscopy between October 2012 and July 2013. Clinical information, including patient willingness to carried colonos-copy, medical history, endoscopic findings, histology, and other information, was collected, and the patients were grouped according APCS scores and the presence of metabolic syndrome components. Colorectal tumor detection rates were compared between the groups .RESULTS: A total of 219 patients were included in the study, 108 were male and 111 were female, resulting in a male-to-female ratio of 1: 1.03. The average age of the patients was 56.8 ± 13.7 years. According to APCS scores, 88 (40.2%) patients were included in the average-risk (AR) group, 113 (51.6%) patients were included in the moderate-risk (MR) group, and 18 (8.2%) patients were included in the high-risk (HR) group. Colorectal tumors were detected in 69 (31.5%) subjects, and the detection rates in the AR, MR, and HR groups were The combined detection rate of colorectal tumors in the APCS MR and HR groups was 42.0%. The combined detection rate of colorectal tumors in the APCS MR and HR groups was 42.0%. The differences in the detection rates between the three groups were statistically significant (P <0.01). , patients in the MR and HR groups who presented with metabolic syndrome components, in particular obesity, exhibited a significantly higher colorectal tumor detection rate (59.5%) than did those without these components (19.2%, P <0.01) and those who underwentwent colonoscopy CONCLUSION: The APCS scoring system can be used in individual screening for sporadic colorectal cancer. The combined use of APCS scores and the metabolic syndrome components, in particular obesity, will significantly improve the efficacy of indiv idual colorectal cancer screening.